| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373322A1 Novel compound for treatment of allergy and asthma |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373249A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 01/02/2004 | EP1373248A1 Benzimidazol derivatives modulate chemokine receptors |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 01/02/2004 | EP1373218A1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373206A1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/02/2004 | EP1372735A2 Conjugate of hydroxyalkyl starch and an active agent |
| 01/02/2004 | EP1372720A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372681A1 Biologically active chloroform fraction of an extract obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372679A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372666A1 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial / matrix adhesion such as asthma, cystic fibrosis and influenza |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372651A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 01/02/2004 | EP1372649A2 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 01/02/2004 | EP1372638A1 Functional role for cannabinoids in autonomic stability during sleep |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372624A2 Tramadol-based medicament |
| 01/02/2004 | EP1372610A2 Powder inhaler formulations |
| 01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
| 01/01/2004 | US20040002613 Synthesis of benzonitriles from substituted benzoic acid |
| 01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002512 Alpha-substituted carboxylic acid derivatives |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002507 Rho-kinase inhibitors |
| 01/01/2004 | US20040002494 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 12/31/2003 | WO2004000863A1 Produrg, medicinal utilization thereof and process for producing the same |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000843A1 NOVEL PURINE- OR PYRROLOL[2,3-d]PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY |
| 12/31/2003 | WO2004000842A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 12/31/2003 | WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 12/31/2003 | WO2004000831A1 Indole derivatives useful as histamine h3 antagonists |
| 12/31/2003 | WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | WO2004000806A1 Amides of cyclic amino acids used as pde 4 inhibitors |
| 12/31/2003 | WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000298A1 Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents |
| 12/31/2003 | WO2004000296A1 (2s)-2amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms |
| 12/31/2003 | WO2004000272A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol |
| 12/31/2003 | WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 12/31/2003 | WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 12/31/2003 | WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 12/31/2003 | WO2003082893A8 Theraputic methods and uses of sapogenins and their derivatives |
| 12/31/2003 | WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/31/2003 | WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands |
| 12/31/2003 | WO2003059288A3 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/31/2003 | WO2002078747A9 Pregabalin lactose conjugates |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | WO2002055075A3 Compounds and methods for regulating cell differentiation |
| 12/31/2003 | WO2002047708A3 Selective cox-2 inhibition from edible plant extracts |
| 12/31/2003 | WO2002047706A3 Selective cox-2 inhibition from plant extracts |
| 12/31/2003 | WO2002043750A8 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| 12/31/2003 | WO2002043578A3 Determination of risk and treatment of complications of prematurity |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
| 12/31/2003 | WO2001006984A3 Small molecules useful in the treatment of inflammatory disease |
| 12/31/2003 | CN1463749A Anti-sphagitis specificity composite IgY and preparation thereof |
| 12/31/2003 | CN1463731A Medicament for treating pulmonary neoplasm, asthma and trachitis and method for making same |
| 12/31/2003 | CN1463729A Health care pillow containing traditional Chinese medicine |